HHC (Hexahydrocannabinol): Effects, risks and legal situation in Germany

Quick overview: What readers want to know immediately

HHC, short for hexahydrocannabinol, is a semi-synthetic cannabinoid produced by chemical conversion of THC or CBD. Since June 2024, HHC has been largely banned in Germany and falls under the New Psychoactive Substances Act (NpSG). What was once considered a supposedly legal alternative to THC is now a Regulated substance with significant legal consequences .

The most important facts at a glance:

• HHC has a psychoactive effect similar to that of Delta 9 THC, but is often described as milder.

• The available research on safety is extremely limited – long-term effects are unknown.

• Since June 27, 2024, the manufacture, trade and distribution of HHC have been prohibited in Germany.

• Possession can be handled differently depending on the quantity and the federal state – always check the current legal situation.

• HHC products were primarily available as vape, gummy bears, oil, and flowers.

Before the ban came into effect, HHC was sold in numerous online shops and stores as a legal substitute for cannabis. Those days are over – but knowledge about this substance remains relevant for anyone who wants to understand its risks and the background of the ban.

What is HHC (hexahydrocannabinol)?

HHC (hexahydrocannabinol) is a hydrogenated derivative of Δ9 THC, the main psychoactive compound in the cannabis plant. In nature, HHC occurs only in trace amounts in cannabis – the quantities are so small that commercial extraction would not be economical. Virtually all HHC products on the market They are therefore produced synthetically or semi-synthetically in the laboratory.

The history of HHC goes back further than many suspect: American chemist Roger Adams described the compound as early as the 1940s and filed corresponding patents. At that time, however, HHC was purely a research object without any practical application. It wasn't until 2021/2022 that the substance suddenly appeared on the drug market as a consumer product – first in the USA, then also in Europe and Germany.

An important aspect for understanding HHC is the existence of two different forms, so-called enantiomers:

• 9β HHC (also called 9R-HHC): The active form with stronger binding to CB1 receptors

• 9α HHC (also called 9S-HHC): The less active form with lower activity psychoactive potency

The manufacturing process typically results in mixtures of both forms, often in a 50:50 ratio. This means that the actual effect of HHC products can vary greatly – depending on the proportion of the active form.

Production and chemical properties of HHC

The production of HHC is a technical process that takes place in specialized laboratories. Understanding the basics of this synthesis is helpful for a complete understanding of the risks.

The classic route to the production of HHC is the hydrogenation of Δ9 THC or Δ8 THC. In this process, hydrogen is added to the THC molecule under pressure and with the aid of metal catalysts – such as palladium, nickel, or the Adams catalyst (named after Roger Adams). This reaction saturates a double bond in the cyclohexyl ring of the structure.

Modern commercial production:

In practice, many manufacturers today use a roundabout method: They first extract CBD from industrial hemp (with less than 0.3% THC), convert it into Delta 8 THC or Delta 9 THC, and then hydrogenate it to produce HHC. This method makes it possible to produce a psychoactive end product from legally grown industrial hemp.

What hydration does:

• Increased stability against light, oxygen and heat

• Longer shelf life (up to 2 years compared to 6 months for THC)

• Altered properties of the molecule

Production problems:

HHC is often produced in unregulated laboratories, sometimes abroad under questionable conditions. This leads to significant quality problems.

• Contamination from heavy metals or reagent residues

• Fluctuating isomer mixtures (15–70% 9R-HHC depending on the batch)

• Lack of standardization and quality controls

• A 2024 study found synthetic byproducts in 40% of the HHC vapes tested.

This variability makes a reliable assessment of the risk for consumers virtually impossible.

Effects of HHC: What happens in the body

Scientific knowledge about the effects of HHC is limited. Many statements are based on animal studies, anecdotal evidence, and initial investigations such as the one by Nasrallah & Garg from 2023. What we do know is that HHC binds to the same receptors as THC and can therefore trigger intoxicating effects in the body.

Interaction with the endocannabinoid system:

• CB1 receptors (brain and nervous system): Responsible for psychoactive effects, mood modulation, and pain perception

• CB2 receptors (immune system): Involved in inflammation regulation and immune response

The binding affinity of HHC lies between CBD and THC – stronger than CBD, but weaker than classic Δ9 THC.

Subjective effects according to consumer reports:

• Euphoria and elevated mood

• Altered sensory perception

• Relaxation and physical well-being

• Increased appetite

• But also: anxiety, paranoia, racing heart, dizziness

The intensity depends heavily on the proportion of the active isomer. Products with a higher 9R-HHC content are more potent, while those with a predominance of 9S-HHC show weaker effects. Consumers report that sometimes significantly higher amounts are needed to experience effects comparable to those of traditional cannabis.

In the body, HHC is metabolized into various metabolites, including 10-OH-HHC and 11-OH-HHC. The effects of these metabolites are still poorly understood. Case reports from clinics and online anecdotal evidence suggest that HHC is sometimes perceived as more unpredictable than conventional cannabis – its effects are delayed, last longer, and their intensity is difficult to gauge.

Risks and side effects: What we know today

Despite its relatively short time on the market, HHC has already been linked to a number of health problems. The data comes from poison control centers, hospital reports, and systematic surveys by authorities such as the German Federal Institute for Risk Assessment.

Typical acute side effects:

• Anxiety and panic attacks

• Elevated blood pressure and accelerated pulse

• Nausea and vomiting

• Severe fatigue or drowsiness

• Coordination problems and dizziness

• Confusion and disorientation

Documented cases of poisoning:

Between 2022 and 2024, serious cases of poisoning were documented in several European countries. Particularly worrying were the hospitalization of children who had accidentally consumed gummy bears containing HHC. Reports from the Czech Republic and Germany indicate that the child-friendly packaging of many food products containing HHC poses a significant risk.

Psychological risks:

In sensitive individuals – especially adolescents and people with pre-existing mental health conditions – the consumption of HHC can trigger or exacerbate the following problems:

• Psychotic episodes

• Depressive moods

• Anxiety disorders

• Depersonalization

Combining it with alcohol or other drugs significantly increases the risk of severe poisoning, loss of control, and accidents. User surveys indicate that 15–20% of users experience paranoia when taking high doses.

Regarding the long-term effects – for example, on memory, motivation, or the cardiovascular system – there is simply a lack of studies for a reliable assessment. This uncertainty was one of the main reasons for the official intervention.

Legal situation: HHC is prohibited in Germany and Europe

The legal development of HHC in Germany follows a clear timeline: from the unregulated grey area to an explicit ban.

Chronology of development:

Period	Development
2021	The first HHC products appear in the USA.
2022	Wider availability in Europe, first shops in Germany
2023	Warnings from the BfR and EMCDDA, political pressure is growing
June 2024	Federal Council decides on inclusion in the NpSG
June 27, 2024	The ban comes into effect

Initially, HHC was not explicitly listed in the narcotics law. Dealers exploited this legal loophole to distribute the substance as a legal THC alternative through shops, e-cigarette stores, and online platforms. Sales of HHC-containing products flourished.

What is now a criminal offense since the ban?

Learn more about new cannabinoids such as 10-OH-HHC and you can find out about their legal situation here.

Following the amendment of the New Psychoactive Substances Act, the following actions are prohibited in Germany:

• Production of HHC and HHC products

• Trade and distribution

• Import and Export

• Possession for commercial purposes

• Online sales of HHC-containing products

The classification covers not only HHC itself, but also an entire group of similar hydrogenated cannabinoids . This is intended to prevent manufacturers from circumventing the law through minimal molecular changes.

Situation in other European countries:

country	Status (as of 2024/2025)
France	Forbidden
Austria	Strictly regulated/prohibited
Finland	Forbidden
Ireland	Forbidden
Czech Republic	Regulated
Switzerland	Regulated

Important NOTE: The legal situation can change. Always check the current state of legislation in each individual case before considering answers to legal questions as binding.

Why the legislature intervened

The ban on HHC is based on clear arguments presented in statements by authorities such as the German Federal Institute for Risk Assessment and the EMCDDA (European Monitoring Centre for Drugs and Drug Addiction).

Key reasons for the ban:

• Health protection: Unclear dosage and a lack of toxicological data made a risk assessment impossible.

• Youth protection: High appeal to minors due to products like gummy bears and vapes

• Unregulated market: No quality controls, variable composition, potential impurities

• Trivialization: Marketing as a food or dietary supplement obscured its psychoactive nature.

HHC products were often disguised as harmless sweets or wellness items. This marketing strategy made it difficult for consumers to assess the actual risk. The ban can therefore be seen as closing a legal gray area – similar to what happened with earlier semi-synthetic cannabinoids and "legal highs" like Spice.

The regulation is primarily preventive in nature: it is intended to prevent an uncontrolled market from becoming established before sufficient data on safety and long-term consequences are available.

HHC compared to THC, CBD and other cannabinoids

Many consumers initially perceived HHC as an alternative to well-known cannabinoids. However, a more detailed comparison reveals significant differences.

HHC vs. THC (Δ9 THC):

aspect	HHC	THC
Psychoactivity	Yes, moderately	Yes, strong
Binding to CB1 receptors	Yes	Yes
Chemical structure	Saturated ring (hydrogenated)	Double bond in the ring
stability	High (light and heat resistant)	Lower
durability	Up to 2 years	Approximately 6 months
State of research	Minimal	Extensive
Legal status DE	Prohibited (NpSG)	Controlled (cannabis as medicine is legal)

The effects of HHC are often described as somewhat milder and longer-lasting than those of classic THC. The energizing, euphoric effects are similar, but many users report a "clearer" experience with less intense psychoactivity.

HHC vs. CBD:

aspect	HHC	CBD
Exhilarating	Yes	No
State of research	Small amount	Well researched
legality	Forbidden	Legal (subject to conditions)
Quality controls	Hardly any presence	Established
Medical application	Not permitted	Approved preparations

The missing entourage effect:

Natural full-spectrum cannabis products contain numerous other cannabinoids and terpenes in addition to the main active ingredient, which work together – the so-called entourage effect. This synergistic effect is completely absent in isolated, semi-synthetic compounds like HHC.

After the HHC ban:

Since the ban, other derivatives have been advertised as "legal" alternatives:

• H4CBD

• CBG (Cannabigerol)

• CBN (Cannabinol)

• 10-OH-HHC

The safety profile of these substances is often just as unclear as that of HHC. Those seeking medical applications should rely on medically prescribed cannabis or approved medications – not on self-procured products from the unregulated market.

Drug tests and detectability

The question of whether HHC is detectable in drug tests is a concern for many potential users. Research on this topic is limited, but initial findings provide important clues.

What we know:

• HHC It is broken down in the body into metabolites such as 11-OH-HHC.

• These metabolites are structurally similar to THC metabolites.

• Standard immunoassays (rapid tests) may, under certain circumstances, respond to HHC metabolites.

• Confirmatory tests (GC-MS/LC-MS) have varying sensitivities.

Practical consequences: Learn more about the Differences and similarities between CC9 and THC and how they can affect the application.

Consumers should not assume that HHC will remain "invisible" during traffic stops or workplace tests. Analytical methods are constantly evolving, and there is no guarantee of negative test results after HHC consumption.

Clear recommendation: Those who rely on negative drug tests – for example, for a driver's license, in sensitive professions, or as part of probation conditions – should consistently avoid HHC and similar novel cannabinoids.

Health protection, prevention and alternatives

The German Federal Institute for Risk Assessment (BfR) has repeatedly warned against HHC products since 2023. The reasons are clear: high risk of intoxication, unclear composition, and a lack of long-term data. A novel THC variant The term THCN is also being increasingly discussed.

Particularly vulnerable groups:

• Children and adolescents (still developing brains)

• Pregnant women and breastfeeding mothers

• People with pre-existing mental health conditions

• People with cardiovascular diseases

Foods containing HHC, such as gummy bears or chocolate, pose a particular risk due to their child-friendly packaging. Accidental consumption by children can lead to severe poisoning and requires immediate medical attention.

Safer alternatives for different needs:

Need	Safe alternative
Pain relief	Medically prescribed cannabis
relaxation	Certified CBD oils with quality certificates
Sleep support	CBN products with laboratory analyses, medical consultation
Wellness	Full-spectrum hemp products without psychoactive substances

For questions about consumption, addiction or health concerns, professional help services are available:

• Addiction counselling centers

• General practitioners and specialists

• Specialized drug counselling facilities

• Telephone advice hotlines

Conclusion: HHC is a chemically interesting but potentially hazardous cannabinoid. The ban primarily serves to protect consumers and young people from an unregulated substance with an unknown risk profile. Anyone wishing to use cannabinoid-based products should opt for legal, quality-tested alternatives and seek medical advice if in doubt.

Developments in the cannabinoid market show that what is advertised as a "legal alternative" today may be banned tomorrow. Always stay informed about the current legal situation and make conscious decisions for your health.